• Mashup Score: 0
    The human factor - 2 year(s) ago

    After 3 years in the making, the type 1 diabetes index (T1D index) was launched on Sep 21, 2022. The T1D index, reported in The Lancet Diabetes & Endocrinology, is an open-source data simulation tool that offers a global comprehensive view of type 1 diabetes by providing new country-level measures of burden and projections of prevalence.

    Tweet Tweets with this article
    • Read our November #Editorial: The human factor https://t.co/JCW09t9bZy #diabetes #registries #T1D #FREE to read

  • Mashup Score: 2
    The human factor - 2 year(s) ago

    After 3 years in the making, the type 1 diabetes index (T1D index) was launched on Sep 21, 2022. The T1D index, reported in The Lancet Diabetes & Endocrinology, is an open-source data simulation tool that offers a global comprehensive view of type 1 diabetes by providing new country-level measures of burden and projections of prevalence.

    Tweet Tweets with this article
    • Online—The human factor https://t.co/JCW09t9bZy #T1D #diabetes #registries #FREE to read

  • Mashup Score: 0
    The human factor - 2 year(s) ago

    After 3 years in the making, the type 1 diabetes index (T1D index) was launched on Sep 21, 2022. The T1D index, reported in The Lancet Diabetes & Endocrinology, is an open-source data simulation tool that offers a global comprehensive view of type 1 diabetes by providing new country-level measures of burden and projections of prevalence.

    Tweet Tweets with this article
    • New Editorial—The human factor https://t.co/JCW09t9bZy #T1D #diabetes #registries #FREE to read

  • Mashup Score: 0

    The key to better understanding the efficacy vs. effectiveness gap in drug therapies could lie in real-world data and patient registries, according to a speaker at the FDA & American College of Rheumatology Virtual Summit. “I think when people are either establishing registries, or they have ongoing registries, exploring ways to build in biobanks, it is going to be increasingly

    Tweet Tweets with this article
    • The key to better understanding the #efficacy vs. effectiveness gap in drug therapies could lie in real-world data and patient #registries @US_FDA @khyrich @HealioRheum https://t.co/aQCBcAU2Pi

    • The key to better understanding the #efficacy vs. effectiveness gap in drug therapies could lie in real-world data and patient #registries #RheumTwitter @US_FDA @khyrich https://t.co/9b2UQ8NFKa

  • Mashup Score: 0

    Population-based cancer registries are crucial for our understanding of cancer burden and to inform cancer policy. They provide data on cancer incidence in a country or region, which aid the setting of priorities for cancer control, the monitoring and evaluation of preventive interventions, and the prediction of the future burden of cancer. When information on vital status is available, registry…

    Tweet Tweets with this article
    • Also in the April issue - New Comment: Quality of #data from #cancer #registries in the Eastern Mediterranean region #EMRO https://t.co/mMPM5kGIaK

  • Mashup Score: 0

    Examine outcomes related to orthopaedics with the AAOS Registry Analytics Institute. Submit a proposal for analytic insights contained in our registries.

    Tweet Tweets with this article
    • The AAOS Registry Analytics Institute is open for proposals from October 4 to November 15. Learn how to apply for Registry data analyses here: https://t.co/GQIwgv0DE8 #OrthoRegistries #registrydata #registries https://t.co/ZfMyt3FYaz

  • Mashup Score: 0

    A study of the American Joint Replacement Registry (AJRR) evaluated its representation of the national experience— an important step in validating AJRR’s potential usefulness in predicting and improving outcomes through data analysis. A study of total hip and knee arthroplasty (THA, TKA) as represented in National (Nationwide) Inpatient Sample (NIS) concluded that, overall, AJRR reasonably…

    Tweet Tweets with this article
    • “Representativeness”: It’s an important concept in gauging value of #registries. A study presented at #AAOS2021 concluded that AAOS cornerstone registry AJRR reasonably reflects national estimates for patient age, sex, race, and hospital size. https://t.co/Rip1zUO08D #AAOSNow https://t.co/9wizbY04i5